The $50 million investment from Astellas Pharma is a significant financial boost for Poseida Therapeutics. This influx of capital can be used for various purposes such as research and development, expansion, or debt repayment, which can improve the company's financial health and future prospects. As a result, investors' confidence in the company may increase, leading to a rise in the demand for its shares and consequently, its share price.